8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001415889-16-005580
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading chromdex8k_apr142016.htm…